Not getting enough sleep does more than make you tired. Here’s how short nights can quietly raise your blood pressure, and ...

CKD prevalence has more than doubled since 1990, with 788 million adults affected in 2023, highlighting a significant global health challenge. The disease is a major contributor to cardiovascular ...

Discover the complexities of Addison's disease in dogs, including diagnosis, treatment options, and management strategies for ...

AstraZeneca and Sun Pharma will jointly market SZC, a key hyperkalaemia drug for CKD and heart failure patients, under ...

AstraZeneca will market the therapy as Lokelma, while Sun Pharma will promote and distribute it as Gimliand. AstraZeneca will ...

AstraZeneca Pharma and Sun Pharma have announced an exclusive partnership to promote and distribute SZC for hyperkalaemia treatment under separate brands, aiming to expand patient access across India ...

AstraZeneca Pharma India and Sun Pharma partner to help patients living with hyperkalaemia in India: Our Bureau, Bengaluru Monday, November 17, 2025, 17:20 Hrs [IST] AstraZeneca P ...

Submission of New Drug Application (NDA) for lorundrostat planned for late-2025/Q1 2026 – – Completed enrollment in Explore-OSA trial; topline results anticipated in Q1 2026 – – Conference call today ...

On Tuesday, shares of AstraZeneca Pharma India surged following the announcement of an exciting alliance with Sun ...

These small lumps grow in the adrenal glands, which sit on top of the kidneys. These glands make hormones, including one ...

RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) reported third-quarter financial results and said it is preparing to ...